BioQ Pharma
The invenious platform aims to enhance safety, efficacy, sterility, value and convenience. BioQ designs ready-to-use delivery systems for hard to prepare and hard to administer infusible drugs – thereby simplifying the infusion process from beginning to end. invenious infusion systems are designed uniquely to each drug’s preparation and dosing requirements. The invenious platform can benefit the end user because of its self-contained delivery system technology that can: Mix the drug and diluent at time of use inside the closed delivery system. Be quickly programmed for diverse dose and flow rates. Reduce administration complexity through a convenient and intuitive interface. BioQ Pharma sells its products through a network of best in class commercial partners worldwide.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Employees:
- 1-10
About Us
BioQ Pharma’s proprietary platform invenious™ transforms infusible medicines into ready-to-use connect-and-go systems
We are a commercial stage company that intends to set a new standard of care in infusion
invenious™ aims to make the delivery of infusible medicines more effective, safer and simpler, while increasing value to patients, providers and payers.
The invenious™ platform comprises a bespoke ‘connect-and-go’ delivery solution for infusible medicines – with all-in-one, pre-filled, ready-to-use and adaptable functions suited to specific dosing regimens.
invenious™ delivery systems are particularly well suited for hard to prepare and/or administer infusibles.
See how invenious™ can help your infusible products
Our invenious™ platform presents the opportunity to build on existing product claims with new benefits to administration like efficiency and safety.
See our current portfolio of invenious™ infusibles
BioQ Pharma’s patented invenious™ connect-and-go technology is already being used to deliver infusible drugs with thoughtfully-designed delivery systems tailored for each drug.
Safety
BioQ Pharma’s product designs are pre-filled and ready-to-use at the point of care. The American Society of Health-System Pharmacists has stated that medication should be provided in the most ready-to-use form to the person responsible for administration.
Our ready-to-use infusion pharmaceuticals are:
- Pre-filled to minimize medication errors
- Designed for the specific dosing regimen of each drug
- Single patient & single use
- Disposable following use
Our ready-to-use infusion pharmaceuticals are intended to minimize medication errors because they are pre-filled by the manufacturer and the dispensing systems dosing capability is uniquely designed around each drug.
Sterility
BioQ Pharma’s infusion pharmaceuticals are presented in self-contained, ready-to-use, unit-dose dispensing systems with sterile drugs. Because the systems are pre-filled at the site of manufacture, manual preparation steps (that often compromise the sterility of the drug) are not required.
Our infusion pharmaceuticals are:
- Presented with sterile drug
- Self-contained
- Ready-to-use at the point of care
- Pre-prepared and require no external drug transfer
Value
Our ready-to-use infusion pharmaceuticals are positioned to create value for patients, providers, and payers by lowering the total cost of drug delivery.
Reducing the number of hands that touch the drug en route to the patient can lower costs by:
- Reducing pharmacy time
- Eliminating filling and preparation steps
- Limiting waste and product expiry
- Enabling early ambulation and mobility
- Reducing nursing time
Convenience
BioQ Pharma’s infusion pharmaceuticals can be immediately deployed at the point-of-care without multiple preparation steps.
The unit-dose infusion packages are:
- Activated with a single touch
- Unit-dose for a single patient
- Drug specific
- Disposable following use
Setting a New Standard of Care in Infusible Pharmaceuticals
Company
BioQ Pharma has proprietary development, regulatory and manufacturing know-how to implement solutions for a wide range of infusible pharmaceuticals. We have the ability to provide a safe, proven and more efficient alternative to reformulation of infusibles.
Our vision to set a new standard of care for infusions is enabled by our invenious™ platform – a technology built to address some of the most pressing unmet needs in infusion today: cost, medication error, sterility, efficiency, and patient quality of life.
For branded pharmaceuticalsThe invenious™ platform could offer a more efficient alternative to reformulation for infusible medicines whose market performance may be held back by complex preparation and administration, as well as those products approaching loss of exclusivity or requiring differentiation (e.g., biosimilars).
For generic pharmaceuticalsOur value proposition objectives for providers, payors, and patients include reducing the potential for medication errors, increasing efficiencies by streamlining logistics and reducing the number of hands that touch the drug en route, thereby enhancing safety and reducing the total cost of drug delivery. We utilize a de-risked commercialization strategy in which BioQ Pharma is the innovator and manager of its network of manufacturing partners to supply finished products to leading pharmaceutical companies for sale under their private label.
Medical Advisors
Our valued advisors
BioQ Pharma has established a valuable group of medical advisors that assists the Company in understanding critical clinical and customer requirements